Company intelligence / Profile preview
MindBio Therapeutics
Vancouver, British Columbia, Canadamindbiotherapeutics.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
MindBio’s proprietary microdose LSD candidate MB22001 has shown promising results. In the completed Phase 2a trial for MDD, after eight weeks of treatment with MB22001 microdosing: "53% of depressed patients entered complete remission after eight weeks... Overall there was an impressive ~60% drop in depressive symptoms at week eight." Phase I showed positive safety/tolerability data plus improvements in mood and sleep metrics. Multiple randomized controlled Phase IIb trials are underway—one focused on MDD (~90 patients), another on late-stage cancer patients experiencing depression/anxiety/existential distress.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Psychedelic microdosing (proprietary titratable LSD formulation)Oral small molecule (MB22001)Digital therapeutics and wearables for monitoring
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
University of Auckland School of PharmacyBlackhawk Growth Corp.New Zealand government
Beyond the preview
Go deeper on MindBio Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MindBio Therapeutics.